Refractory chronic cough (RCC), which often persists for years and has significant repercussions for patient’s physical, emotional, and social wellbeing, can be a difficult condition to diagnosis. Further, a lack of FDA-approved treatment options specific to chronic cough has challenged healthcare professionals managing patients with the condition. Recently, better understanding of the pathogenesis of RCC has prompted the investigation of novel mechanisms of action that are showing promise for patients with RCC. Tune into this live webinar to hear two interdisciplinary RCC experts discuss the advances occurring in RCC care and gain insights into the patient journey. This program will also feature an animation that will anchor the discussion of pathogenesis and novel mechanisms of action that are currently under late-stage clinical investigation.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/virtual/uncovering-pathogenesis-patient-experience-refractory-chronic-cough
- Start Date: 2025-02-25 06:00:00
- End Date: 2025-02-25 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: GlaxoSmithKline - Amount: 33000.0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all